Cargando…
Adenylyl cyclase-associated protein 1-targeted nanoparticles as a novel strategy for the treatment of metastatic non-small cell lung cancer
Non-small cell lung cancer (NSCLC) is one of the most fatal cancers worldwide. Adenylyl cyclase-associated protein 1 (CAP1) belongs to a family of cyclase-associated proteins that are involved in the development of cancerous tumors. A previous study by our group confirmed the association between CAP...
Autores principales: | Liu, Yang, Xie, Shuanshuan, Zeng, Jie, Song, Xiaolian, Tan, Min, He, Dannong, Wang, Jie, Wang, Ping, Zhu, Jun, Wang, Changhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6615927/ https://www.ncbi.nlm.nih.gov/pubmed/31173184 http://dx.doi.org/10.3892/ijo.2019.4822 |
Ejemplares similares
-
Systematic analysis of gene expression alterations and clinical outcomes of adenylate cyclase-associated protein in cancer
por: Xie, Shuanshuan, et al.
Publicado: (2017) -
CDK5 Functions as a Tumor Promoter in Human Lung Cancer
por: Zeng, Jie, et al.
Publicado: (2018) -
Analysis of sputum microbial metagenome in COPD based on exacerbation frequency and lung function: a case control study
por: Li, Wei, et al.
Publicado: (2022) -
New Perspectives on Plant Adenylyl Cyclases
por: Ruzvidzo, Oziniel, et al.
Publicado: (2019) -
Expression and functions of adenylyl cyclases in the CNS
por: Devasani, Karan, et al.
Publicado: (2022)